HLN Haleon (HLN) Insider Trading, Ownership & Congress Trades
Consumer Goods · Perfumes, cosmetics & other toilet preparations · CIK 0001900304
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
305
13F, latest reported quarter
What the filings say about HLN
Congress, 1 year
No trades
Last one: sale, 2025-09-23
Haleon insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
No insider purchases or sales are on record for Haleon plc in the period covered. Source: SEC Form 4 filings, as of 2026-10-27.
Foreign private issuer: its insiders are exempt from SEC Form 4 and report in the home market, so their buys and sells do not appear here.
Insider
Filed
Shares
Value
Since filing
no insider purchases or sales on record
0 transactions on record
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
no insider buys or sells on file
Congress
no House purchase disclosed in the last 12 months
Funds
305 funds bought in last quarter
more than 84% of Consumer Goods
Revenue
no revenue reported in any filing
Margin
no margin: no revenue reported
Buybacks
no share repurchases reported
Short interest
0.6% of the float short (float per yahoo 2026-10-26) · 1.0 days to cover · settled 2026-09-30
below 79% of Consumer Goods
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch HLN
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
Who owns HLN: institutional holders (13F)
13F holdings, latest reported quarter
149,934,507 sh
$1.4B
120,991,250 sh
$1.1B
32,342,126 sh
$301.8M
19,461,762 sh
$181.6M
16,833,252 sh
$157.1M
Congress trades in HLN
STOCK Act disclosures, US House only, filed up to 45 days after the trade
Sold 2025-09-23 · disclosed 17 days later
$1,001 - $15,000
Sold 2025-07-10 · disclosed 34 days later
$1,001 - $15,000
Bought 2025-06-24 · disclosed 50 days later
$1,001 - $15,000
Sold 2025-04-09 · disclosed 35 days later
$1,001 - $15,000
Bought 2024-10-29 · disclosed 318 days later
$1,001 - $15,000
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
HLN planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
HLN mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
GMO International Quality ETF
$9.9M position · as of 2026-05-31
3.5%
VanEck Pharmaceutical ETF
$27.2M position · as of 2026-06-30
3.1%
Domini Sustainable Solutions Fund
$1.4M position · as of 2026-07-31
2.5%
Guinness Atkinson Dividend Builder ETF
$939.5K position · as of 2026-06-30
2.4%
International Developed Markets Select Equity ETF
$2.1M position · as of 2026-07-31
2.3%
Franklin ClearBridge Enhanced Income ETF
$3.7M position · as of 2026-06-30
2.3%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Clinical pipeline
63 registered trials, 9 still running (ClinicalTrials.gov).
A status change is dated here weeks before the press release.
9
Phase 1
1 active
3
Phase 3
0 active
7
Phase 4
1 active
44
Not applicable
7 active
What changed recently
A Clinical Study to Assess the Effectiveness of Use of Three Experimental Denture Adhesi
2026-10-21 · Recruiting → Completed
Not applicable
The Study to Evaluate the Plaque Control and Anti-Gingivitis Efficacy of a Toothpaste in
2026-10-21 · Not Yet Recruiting → Recruiting
Not applicable
A Study Investigating Gingival Crevicular Fluid Biomarkers Following Use of a Commercial
2026-10-10 · Not Yet Recruiting → Recruiting
Not applicable
A Study to Assess the Efficacy of an Experimental Mouthwash Used With a Marketed Whiteni
2026-10-08 · Not Yet Recruiting → Recruiting
Not applicable
A Study to Investigate the Efficacy of an Experimental Dentifrice Containing Stannous Fl
2026-10-08 · Recruiting → Completed
Not applicable
Matched by sponsor name. Trials run under a subsidiary's
own name are not included.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows 305 funds added last quarter. Each figure is a federal filing, dated the day it went public.
HLN financials
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Gross profit | $7.1B | $6.8B | $6.7B | $6.6B |
| Net income | $1.7B | $1.5B | $1.1B | $1.1B |
SEC XBRL, fiscal years, as known on 2026-10-27
HLN Stock Sonar score 2/7 axes
Find similar shapesCompare2 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
HLN filings, in plain words
Have members of Congress traded HLN?
Yes, but not in the year to 2026-10-27; the latest on record is a sale by Valerie Hoyle dated 2025-09-23.
Read the full summary
Members of Congress have disclosed trades in HLN, none in the last year; the latest on record is a sale by Valerie Hoyle dated 2025-09-23. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
